De-acetylation and degradation of HSPA5 is critical for E1A metastasis suppression in breast cancer cells

Elevated expression of heat shock protein 5 (HSPA5) promotes drug resistance and metastasis and is a marker of poor prognosis in breast cancer patients. Adenovirus type 5 E1A gene therapy has demonstrated antitumor efficacy but the mechanisms of metastasis-inhibition are unclear. Here, we report tha...

Full description

Saved in:
Bibliographic Details
Published inOncotarget Vol. 5; no. 21; pp. 10558 - 10570
Main Authors Chang, Yi-Wen, Chen, Hsin-An, Tseng, Chi-Feng, Hong, Chih-Chen, Ma, Jui-Ti, Hung, Mien-Chie, Wu, Chih-Hsiung, Huang, Ming-Te, Su, Jen-Liang
Format Journal Article
LanguageEnglish
Published United States Impact Journals LLC 15.11.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Elevated expression of heat shock protein 5 (HSPA5) promotes drug resistance and metastasis and is a marker of poor prognosis in breast cancer patients. Adenovirus type 5 E1A gene therapy has demonstrated antitumor efficacy but the mechanisms of metastasis-inhibition are unclear. Here, we report that E1A interacts with p300 histone acetyltransferase (HAT) and blocks p300-mediated HSPA5 acetylation at K353, which in turn promotes HSPA5 ubiquitination by GP78 (E3 ubiquitin ligase) and subsequent proteasome-mediated degradation. Our findings point out the Ying-Yang regulation of two different post-translational modifications (ubiquitination and acetylation) of HSPA5 in tumor metastasis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.2510